| scholarly article | Q13442814 |
| P2093 | author name string | Cantoni L | |
| Bille J | |||
| Glauser MP | |||
| P2860 | cites work | LY146032 compared with penicillin G in experimental aortic valve endocarditis caused by group G streptococci | Q35289979 |
| Daptomycin (LY146032) treatment of experimental enterococcal endocarditis | Q35309352 | ||
| Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis | Q35541055 | ||
| Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies | Q35541070 | ||
| Discrepancies between MBC and actual killing of viridans group streptococci by cell-wall-active antibiotics | Q35648694 | ||
| Natural history of aortic valve endocarditis in rats | Q36328909 | ||
| Early stages of in vitro killing curve of LY146032 and vancomycin for Staphylococcus aureus | Q39817922 | ||
| Daptomycin (LY146032) for prevention and treatment of experimental aortic valve endocarditis in rabbits | Q39819894 | ||
| In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci | Q39827756 | ||
| Influence of the developmental state of valvular lesions on the antimicrobial activity of cefotaxime in experimental enterococcal infections | Q39833901 | ||
| In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic | Q39834787 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Staphylococcus aureus | Q188121 |
| cloxacillin | Q422219 | ||
| vancomycin | Q424027 | ||
| P304 | page(s) | 2348-2353 | |
| P577 | publication date | 1990-12-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination | |
| P478 | volume | 34 |
| Q58616701 | A dual function antibiotic-transporter conjugate exhibits superior activity in sterilizing MRSA biofilms and killing persister cells |
| Q41754792 | Antibiotic prophylaxis and the medically compromised patient |
| Q35078077 | Bactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: looking for a relationship between tolerance and outcome |
| Q35820407 | Beta-lactams versus glycopeptides in treatment of subcutaneous abscesses infected with Staphylococcus aureus |
| Q34303042 | Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections |
| Q35637066 | Daptomycin |
| Q34721715 | Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin |
| Q36744825 | Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus |
| Q54034073 | Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests. |
| Q36003721 | Daptomycin: a cyclic lipopeptide antimicrobial agent |
| Q53852746 | Daptomycin: a novel agent for Gram-positive infections. |
| Q33920377 | Development of daptomycin for gram-positive infections |
| Q28361569 | Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance |
| Q39867979 | Efficacy of ticarcillin-clavulanic acid for treatment of experimental Staphylococcus aureus endocarditis in rats |
| Q33239640 | Evaluation of high-dose daptomycin for therapy of experimental Staphylococcus aureus foreign body infection |
| Q40855566 | Fear of MRSA--potential for future disaster |
| Q36095086 | Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus |
| Q40088863 | In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin |
| Q40950966 | Inappropriate vancomycin prescribing based on criteria from the Centers for Disease Control and Prevention |
| Q42929761 | Lack of bactericidal antagonism or synergism in vitro between oxacillin and vancomycin against methicillin-susceptible strains of Staphylococcus aureus |
| Q37860558 | New trends in infective endocarditis |
| Q34666658 | Novel agents for resistant Gram-positive infections--a review |
| Q56928143 | Perioperative Antibiotics |
| Q35688447 | Pharmacokinetic and pharmacodynamic issues in the treatment of bacterial infectious diseases |
| Q35940556 | Predictors of mortality in Staphylococcus aureus Bacteremia |
| Q35750208 | Prophylactic use of vancomycin in adult cardiology and cardiac surgery |
| Q40690496 | Protracted and recurrent methicillin-resistant Staphylococcus aureus bacteremia despite defervescence with vancomycin therapy |
| Q34783668 | Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia |
| Q56794091 | Retos en el tratamiento antimicrobiano de la endocarditis infecciosa. Papel de la daptomicina |
| Q33750776 | Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin |
| Q40517235 | The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents |
| Q44468680 | Vancomycin for Staphylococcus aureus therapy of respiratory tract infections: the end of an era? |
| Q35879117 | Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia |
| Q37802885 | Vancomycin-resistant enterococcal urinary tract infections |
| Q34443407 | What do we really know about antibiotic pharmacodynamics? |
Search more.